Legal & General Group
MGNX icon

Legal & General Group’s MacroGenics MGNX Stock Holding History

Legal & General Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,140
Closed -$7.8K – 3487
2025
Q1 		$7.8K Hold
6,140
– – ﹤0.01% 3221
2024
Q4 		$20K Sell
6,140
-312
-5% -$1.12K ﹤0.01% 3022
2024
Q3 		$21.2K Sell
6,452
-41,507
-87% -$162K ﹤0.01% 3024
2024
Q2 		$204K Sell
47,959
-3,822
-7% -$37.2K ﹤0.01% 2663
2024
Q1 		$762K Buy
51,781
+42,324
+448% +$640K ﹤0.01% 2281
2023
Q4 		$91K Buy
9,457
+1,358
+17% +$9.39K ﹤0.01% 2766
2023
Q3 		$37.7K Sell
8,099
-793
-9% -$3.95K ﹤0.01% 2900
2023
Q2 		$47.6K Buy
8,892
+3,144
+55% +$19.4K ﹤0.01% 2880
2023
Q1 		$41.2K Hold
5,748
– – ﹤0.01% 2910
2022
Q4 		$38.6K Sell
5,748
-11,413
-67% -$62.6K ﹤0.01% 2984
2022
Q3 		$60K Buy
17,161
+129
+0.8% +$493 ﹤0.01% 2938
2022
Q2 		$50K Sell
17,032
-4,180
-20% -$22K ﹤0.01% 3000
2022
Q1 		$187K Sell
21,212
-13
-0.1% -$144 ﹤0.01% 2689
2021
Q4 		$340K Buy
21,225
+756
+4% +$14.2K ﹤0.01% 2533
2021
Q3 		$429K Buy
20,469
+9,296
+83% +$224K ﹤0.01% 2458
2021
Q2 		$300K Buy
11,173
+1,541
+16% +$45.1K ﹤0.01% 2440
2021
Q1 		$307K Buy
9,632
+234
+2% +$5.68K ﹤0.01% 2374
2020
Q4 		$215K Buy
9,398
+142
+2% +$3.27K ﹤0.01% 2400
2020
Q3 		$234K Sell
9,256
-1,610
-15% -$44K ﹤0.01% 2327
2020
Q2 		$304K Buy
10,866
+548
+5% +$9.52K ﹤0.01% 2275
2020
Q1 		$60K Sell
10,318
-1,678
-14% -$15.2K ﹤0.01% 2544
2019
Q4 		$131K Buy
11,996
+874
+8% +$8.65K ﹤0.01% 2511
2019
Q3 		$141K Buy
11,122
+2,063
+23% +$29.7K ﹤0.01% 2431
2019
Q2 		$154K Buy
9,059
+1,627
+22% +$27.9K ﹤0.01% 2420
2019
Q1 		$134K Hold
7,432
– – ﹤0.01% 2417
2018
Q4 		$94K Buy
7,432
+1,261
+20% +$21.1K ﹤0.01% 2477
2018
Q3 		$132K Hold
6,171
– – ﹤0.01% 2432
2018
Q2 		$128K Sell
6,171
-311
-5% -$7K ﹤0.01% 2418
2018
Q1 		$163K Sell
6,482
-2,504
-28% -$60.8K ﹤0.01% 2350
2017
Q4 		$171K Buy
8,986
+247
+3% +$4.61K ﹤0.01% 2379
2017
Q3 		$161K Buy
8,739
+814
+10% +$14.1K ﹤0.01% 2418
2017
Q2 		$138K Buy
7,925
+328
+4% +$6.26K ﹤0.01% 2444
2017
Q1 		$138K Sell
7,597
-116
-2% -$2.24K ﹤0.01% 2392
2016
Q4 		$156K Buy
7,713
+3,121
+68% +$78.6K ﹤0.01% 2325
2016
Q3 		$136K Sell
4,592
-300
-6% -$8.92K ﹤0.01% 2131
2016
Q2 		$132K Hold
4,892
– – ﹤0.01% 1951
2016
Q1 		$89K Buy
4,892
+983
+25% +$18.7K ﹤0.01% 2129
2015
Q4 		$121K Hold
3,909
– – ﹤0.01% 1961
2015
Q3 		$82K Hold
3,909
– – ﹤0.01% 2155
2015
Q2 		$142K Hold
3,909
– – ﹤0.01% 1889
2015
Q1 		$125K Hold
3,909
– – ﹤0.01% 1897
2014
Q4 		$137K Hold
3,909
– – ﹤0.01% 1776
2014
Q3 		$79K Buy
+3,909
New +$80.8K ﹤0.01% 2070

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Legal & General Group's MGNX Position: Q2 2025 in Review

Legal & General Group sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 6,140 shares — an estimated $7.8K sold.

Legal & General Group first reported a position in MGNX in Q3 2014 and held it in 43 quarters. The position peaked at $762K in Q1 2024. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Legal & General Group reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 6,140 MacroGenics shares in Q2 2025, an estimated $7.8K.
  • Legal & General Group first reported a position in MacroGenics in Q3 2014 and held it in 43 quarters.
  • Legal & General Group's MacroGenics position peaked at $762K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.